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through activation of PI3K/Akt pathway
Liufeng Mao1, Wanhua Lin2,3, Tao Nie1, Xiaoyan Hui4, Xuefei Gao5, Kuai Li1, Mengxiao Ding1, Xiaofeng Tang1,
Peng Li1, Yu Wang4, Aimin Xu4, Pentao Liu5 and Donghai Wu1*Abstract
Background: The adapter proteins Appl1 (adaptor protein containing pleckstrin homology domain, phosphotyrosine
domain, and leucine zipper motif 1) and Appl2 are highly homologous and involved in several signaling pathways.
While previous studies have shown that Appl1 plays a pivotal role in adiponectin signaling and insulin secretion, the
physiological functions of Appl2 are largely unknown.
Results: In the present study, the role of Appl2 in sepsis shock was investigated by using Appl2 knockout (KO) mice.
When challenged with lipopolysaccharides (LPS), Appl2 KO mice exhibited more severe symptoms of endotoxin shock,
accompanied by increased production of proinflammatory cytokines. In comparison with the wild-type control, deletion
of Appl2 led to higher levels of TNF-α and IL-1β in primary macrophages. In addition, phosphorylation of Akt and its
downstream effector NF-κB was significantly enhanced. By co-immunoprecipitation, we found that Appl2 and Appl1
interacted with each other and formed a complex with PI3K regulatory subunit p85α, which is an upstream regulator of
Akt. Consistent with these results, deletion of Appl1 in macrophages exhibited characteristics of reduced Akt activation
and decreased the production of TNFα and IL-1β when challenged by LPS.
Conclusions: Results of the present study demonstrated that Appl2 is a critical negative regulator of innate immune
response via inhibition of PI3K/Akt/NF-κB signaling pathway by forming a complex with Appl1 and PI3K.
Keywords: Appl2, Appl1, Endotoxin shock, Inflammatory cytokines, PI3K, Akt, NF-κBBackground
Severe sepsis, or septic shock, represents one of the oldest
problems in medicine. In the United States, severe sepsis
composes 2% of patients admitted to the hospital [1]. Sep-
tic shock is caused by severe infection of the invading mi-
crobes that produces endotoxin from Gram-negative
bacteria or analogous molecules from gram-positive bac-
teria or other fungi. Endotoxins are bacterial membrane li-
popolysaccharides (LPS) and are the major component of
the outer membranes in Gram-negative bacteria. In
Gram-negative sepsis, LPS (endotoxin) induces profound
activation of macrophages and production of potent in-
flammatory cytokines such as TNF-α, IL-1 and IL-6 [2].
These proinflammatory cytokines act on endothelial cells
to cause systemic vasodilatation, diminished myocardial
contractility, endothelial injury and activation, resulting* Correspondence: wu_donghai@gibh.ac.cn
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unless otherwise stated.in disseminated intravascular coagulation. The hypo-
perfusion in turn leads to multi-organ failure that affects
the liver, kidneys, and central nervous system.
LPS elicits its biological effects by forming a complex
with CD14, LBP, TLR4, and MD-2, which triggers several
intracellular signal pathways to activate NF-κB [3]. NF-
κB is a transcriptional factor containing five subunits,
namely, relA/p65, relB, c-Rel, p105/p50, and p100/p52,
which function as homo- or hetero-dimers. In resting
macrophages, NF-κB dimers reside in the cytoplasm and
bind with specific inhibitory IκB proteins. When stimu-
lated by LPS, IκB kinase (IKK) phosphorylates IκB, lead-
ing to its degradation, thereby releasing NF-κB for
nuclear translocation where it facilitates the expression
of various inflammatory and stress response genes [4-7].
Jun N-terminal kinase, p38 mitogen-activated protein
kinase, and Akt pathways have been reported to activate
NF-κB. Among these pathways, Akt stimulates NF-κB by
phosphorylating and activating the NF-κB p65/RelAd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Decreased expressions of Appl2 in primary
macrophages treated with LPS. (A) Western blot analysis of Appl2
in peritoneal macrophages from WT mice stimulated with 1 μg/mL
LPS at specified time points. (B) The density analysis of the above
data using NIH Image J software for relative values. *p < 0.05,
compared with control, n = 5.
Figure 2 Generation and validation ofAppl2 KO mice.
(A) Diagram showing the construction of Appl2 KO mouse. (B) Western
blot analysis demonstrating the absence of the Appl2 protein in the
macrophages of Appl2 KO mice. Appl2−/−, Appl2 KO mouse.
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cascade [8-12].
Appl1 and Appl2 are homologous proteins that bind
to a diverse set of transmembrane receptors or signaling
proteins. Appl1 was originally identified as an intracellu-
lar binding partner of adiponectin receptor and mediates
adiponectin-dependent insulin sensitization in skeletal
muscle [13,14]. Appl1 plays an essential role in inflam-
matory responses, depending on the cell type. Specific-
ally, adiponectin was shown to either suppress NF-kB
activity in endothelial cells and adipocytes or to activate
the NF-kB pathway in synovial or cardiac fibroblasts
[15-20]. Appl1 also participates in PI3K/Akt signaling
pathway since it was reported to induce the phosphoryl-
ation of Akt and to stimulate the transactivation of the
p65 subunit of NF-κB through the IKK [21]. Appl1
transgenic mice showed less peripheral insulin resistance
and cardiac dysfunction in response to high fat diet with
enhanced Akt phosphorylation and glucose uptake in
cardiomyocyte [22]. Additionally, Tan et al. has reported
that Appl1 possesses growth factor-selective effects on
Akt signaling in mouse embryonic fibroblasts [23].
On the other hand, the physiological functions of
Appl2 are less clear. Whether Appl2 plays a role in in-
flammatory responses has not yet been studied. How-
ever, since it was demonstrated by several subsequent
studies that Appl2 down-regulated adiponectin signaling
by forming a Yin-Yang regulatory pair with Appl1, it is
important to examine whether Appl2 plays a negative
regulatory role in inflammation [24,25].
In this study, Appl2 knockout (KO) mouse was gener-
ated and its response to LPS-induced endotoxin shock
was investigated. When challenged with LPS, Appl2 KO
mice had more exacerbated symptoms of endotoxin
shock. In accordance with this, circulating levels and
production of proinflammatory cytokines in Appl2 KO
mice and macrophages were markedly elevated in com-
parison to their controls. Further analysis demonstrated
that Appl2 modulated Akt-NF-κB signaling pathway,
possibly by competitively binding to the p85 subunit of
PI3K. Results of the present study suggest that Appl2
functions as a negative regulator of innate immune re-
sponse via Akt pathway.
Results
Generation of Appl2 KO mice
To study the role of Appl2 in inflammatory responses,
the expression of Appl2 in mouse primary macrophages
was examined during acute LPS stimulation. The expres-
sion of Appl2 decreased steadily (Figure 1) in response
to LPS, suggesting that Appl2 may have distinct func-
tions in the inflammatory responses. To better under-
stand its role in inflammation, Appl2 KO mice were
generated as described in the method. The deletion ofAppl2 in these mice was confirmed by Western blot
analysis in primary peritoneal macrophages (Figure 2).Appl2 KO mice are more prone to endotoxic shock when
challenged by LPS
To examine the roles of Appl2 in regulating inflamma-
tory responses, the Appl2 KO mice were subjected to
LPS challenge and the phenotypes were examined. The
mice were intraperitoneally injected with indicated doses
of LPS, and the survival rate of the mice was monitored.
At a dose of 20 mg /kg LPS, the Appl2 KO mice showed
more severe symptoms of endotoxin shock and higher
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Survival analysis showed that the survival rate of the
Appl2 KO mice was significantly lower than that of the
WT mice after injection of LPS.
A critical feature of endotoxic shock is disseminated
intravascular coagulation, which is characterized by
widespread blood coagulation and vessel hemorrhage,
particularly in the kidney. After challenge with the indi-
cated doses of LPS, a histological examination of the
kidneys was performed. Appl2 KO mice exhibited server
hemorrhage in their kidneys when the WT mice did not
show any obvious tissue damage at the dose of LPS
(Figure 3C). The TNFα and IL-1β serum levels wereFigure 3 Appl2 KO mice are more prone to endotoxic shock than WT
KO (n = 9) mice after LPS challenge (20 mg/kg weight, intraperitoneal injec
susceptible to the endotoxin challenge. (B) Photographs of the WT and Ap
showed only mild effects, whereas the Appl2 KO mice exhibited typical sig
post-LPS challenge. (D) Mouse serum TNFα level at 60 min after LPS injecti
KO and control mice. Scale bar: 50 μm; *p < 0.05, compared with WT mice,subsequently measured since TNFα and IL-1β are crit-
ical proinflammatory cytokines that respond to endo-
toxic shock elicited by LPS. Compared with the WT
mice, the serum levels of TNFα and IL-1β were higher
in the Appl2 KO mice (Figure 3D-E).
Increased production of TNFα and IL-1β in Appl2 KO
macrophages
Macrophages are the major target cells of LPS stimula-
tion that produce proinflammatory cytokines; thus, the
peritoneal primary macrophages were harvested and
stimulated with LPS in vitro. After LPS stimulation, the
production of cytokines secreted into the medium in themice. (A) Kaplan-Meier survival curves of the WT (n = 9) and the Appl2
tion). Compared with the WT mice, the Appl2 KO mice were more
pl2 KO mice 24 h after intraperitoneal injection of LPS. WT mice
ns of endotoxemia. (C) HE-stained kidney sections from mice at 24 h
on. (E) Time course of the IL-1β expression in the LPS-stimulated Appl2
n = 6.
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kinetics of TNF-α and IL-1β cytokine expressions were
monitored. Compared with the macrophages isolated
from WT mice, the production of TNF-α and IL-1β was
significantly enhanced in macrophages from Appl2 KO
mice upon LPS stimulation (Figure 4A-B). These results
suggest that loss of Appl2 enhances the proinflammatory
cytokine in the primary macrophage in response to LPS
challenge.
Enhanced activation of Akt-NF-κB pathways after LPS
stimulation in Appl2 KO macrophages
Thus, whether LPS can activate the Akt pathway was
first examined. In Figure 5, compared with the LPS-
stimulated WT mice macrophage, phospho-Akt was en-
hanced in Appl2 KO mice macrophages. Subsequently,
the activation of the p65 subunit of NF-κB was also
examined, which can be regulated through the Akt path-
way. In macrophages from Appl2 KO mice, phospho-
IKKβ, IκB, and p65 were enhanced compared with the
WT macrophages (Figure 5). These data suggest that the
Appl2 can regulate inflammation through the Akt path-
way for NF-κB activation.
The p85 subunit of PI3K associates with Appl2 and Appl1
Appl isoforms interact with many different membrane
receptors and others proteins. MyD88 dependent toll-
like receptor 4 (TLR4)signaling pathway is a major re-
ceptor for LPS in mediating innate immune response
[26]. To further pin down the molecular mechanism by
which Appl2 modulates inflammation, we first examined
whether there exists an interaction between Appl2with
TLR4 and MyD88. Immunoprecipitation results demon-
strated that Appl2 has weak interaction with TLR4 but
no interaction with MyD88. Moreover, Appl2 was found
to strongly interact with p85α subunit of PI3K and Appl1.
Meanwhile we also found Appl1 could interact with p85α
subunit of PI3K and Appl2 (Figure 6).Figure 4 Increased production of TNFα and IL-1β in Appl2 KO
macrophages. (A) Kinetics of TNFα expression in the LPS-stimulated
primary macrophages of the Appl2 KO and control mice. (B) Kinetics
of IL-1β expression in the LPS-stimulated primary macrophages of
the Appl2 KO and control mice. *p < 0.05, compared with WT mice,
n = 5.Appl1 KO mice show less severe endotoxic shock than
WT mice
To better understand their roles in inflammation, Appl1
KO mice were generated (Figure 7A-B). At 30 mg/kg
LPS challenge, the Appl1 KO mice showed less severe
endotoxic shock and lower mortality compared with the
WT mice (Figure 3C-D). After the indicated doses of
LPS challenge, a histological examination of the kidneys
was performed. Compared with the WT mice, the Appl1
KO mice showed less widespread hemorrhage in their
kidneys (Figure 7E), and lower production of TNFα and
IL-1β in serums (Figure 7F-G).
Reduced production of TNFα and IL-1β and decreased
activation of Akt-NF-κB pathways after LPS stimulation in
Appl1 KO macrophages
The kinetics of TNFα and IL-1β cytokine expressions
was also examined to monitor the dynamic change in
cytokine levels at designated periods after challenged by
LPS. Compared with the macrophages from WT mice,
the production of TNFα and IL-1β reduced significantly
in the LPS-stimulated macrophages from the Appl1 KO
mice (Figure 8A-B). Appl1 was mainly identified to inter-
act with Akt and increase the phosphorilation of Akt.
Phosphor-Akt can stimulate the transactivation of the p65
subunit of NF-κB through the IκB kinase. Thus, whether
LPS can activate the Akt pathway was examined. In
Figure 8C-D, compared with the LPS-stimulated WT mice
macrophage, phosphor-Akt was attenuated in Appl1 KO
mice macrophages. Phosphor-IKKβ, IκB, and p65 were
also reduced compared with the WT mice macrophages.
These data suggest that the Appl1 can regulate inflamma-
tion through the Akt pathway for NF-κB activation.
Discussion
Mounting evidence demonstrates that App11 is an im-
portant mediator of insulin sensitivity and inflammatory
response in adiponectin signaling pathways [27]. How-
ever, the cellular functions of Appl2 and its relationships
with App11 remain poorly understood [24]. In order to
examine the possible involvement of Appl2 in inflamma-
tion, the level of Appl2 was determined in the primary
macrophages in response to LPS stimulation. The ex-
pression of Appl2 decreased gradually, suggesting that
Appl2 may be involved. Indeed, Appl2 KO mice showed
more severe endotoxin shock compared with the WT
mice when challenged with LPS.
Since PI3K/Akt pathway was well known to be essen-
tial in LPS-induced acute inflammation [28] and Appl1
was shown to regulate Akt activity and substrate specifi-
city [29], it is of interest to examine the relationship be-
tween Appl2 and Akt in inflammatory reaction. Thus,
we next investigated whether the LPS-stimulated Akt
pathway can be affected in the primary macrophages
Figure 5 Enhanced activation of Akt-NF-κB pathways after LPS stimulation in Appl2 KO macrophages. Peritoneal macrophages derived
from peritoneal cells were stimulated with 1 μg/mL LPS for 20 min. The cell lysates were analyzed by western blot. (A) Western blot analysis on
peritoneal macrophages from APPL2 KO mice with the indicated antibodies. (B) The ratio values of p-Akt/Akt/β-actin, p-IKKβ/IKKβ/β-actin, p-IκB/
IκB/β-actin, p-p65/p65/β-actin as determined by the density analysis of (A) using NIH Image J software for relative values. *p < 0.05, compared
with WT mice, n = 5.
Figure 6 The p85α subunit of PI3K associates with Appl 1 and 2.
Peritoneal macrophages from WT mice were treated with 1 μg/mL LPS
for 20 min. Macrophages lysates were immunoprecipitated with IgG,
Appl2 and Appl1 antibody and immuoblotted using antibodies against
TLR4, MyD88, Akt, p85α, Appl1 and Appl2, respectively.
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was enhanced in the LPS treated primary macrophages
from the Appl2 KO mice compared with that from the
WT mice. These results appear to be consistent with
those of previous reports, wherein Appl1 and Appl2
were able to facilitate Akt activation through yin-yang
regulation in the muscle cells, and the fact that phosphor-
ylation of Akt as well as glucose uptake were enhanced in
Appl2 KO mice [24,30]. The higher level of Akt activity
may be responsible for the enhanced expression of NF-kB
and subsequent more aggressive inflammatory reaction in
Appl2 KO mice when challenged by LPS.
TLRs are a class of proteins that play a key role in the
innate immune system as well as the digestive system.
Activation of TLR signaling through recognition of
pathogen-associated molecular patterns leads to the
transcriptional activation of genes encoding for pro-
inflammatory cytokines and chemokines by the way of
PI3K/Akt, which in turn control the activation of
antigen-specific adaptive immune response [31]. To
understand the concise mechanism of Appl2 that regu-
lates inflammation, we hypothesized that Appl2 may
interact with the TLR4 receptor because it has been re-
ported to increase Akt phosphorylation in a TLR4 high
expression cell line [32-34]. Opposite to our expectation,
binding between the Appl2 and TLR4 was not observed.
MyD88 is an important protein in TLR signaling path-
ways by dimerizing with the TLR receptors [26].Binding
between the Appl2 and MyD88 was not observed either.
Some study showed that MyD88 can form a complex
with PI3-kinase, an important regulatory protein of Akt
[26,35]. Therefore, Appl2 may be involved in the down-
stream of TLR4 pathway. As expected, PI3K apparently
Figure 7 (See legend on next page.)
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Figure 7 Appl1 KO mice show less severe endotoxic shock than WT mice. (A) Diagram showing the construction of Appl1 KO mouse.
(B) Western blot analysis demonstrating the absence of the Appl1 protein in the macrophages of Appl1KO mice. (C) Kaplan-Meier survival curves
of the WT (n = 9) and the Appl1 KO (n = 9) mice after LPS challenge (30 mg/kg weight, intraperitoneal injection). Compared with the WT mice,
the Appl1 KO mice were less susceptible to the endotoxin challenge. (D) Photographs of the WT and Appl1 KO mice 24 h after intraperitoneal
injection of LPS. Appl1 KO mice showed only mild effects, whereas WT mice exhibited typical signs of endotoxemia. (E) HE-stained kidney sections
from mice at 24 h post-LPS challenge. (F) Mouse serum TNFα level at 60 min after LPS injection. (G) Kinetics of the IL-1β expression in the LPS-
stimulated Appl1 KO and control mice. Scale bar: 50 μm; Appl1−/−, Appl1 KO mouse; *p < 0.05, compared with WT mice, n = 6.
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those of a previous paper, wherein Appl2 suppresses in-
sulin signaling pathway and Akt phosphorylation in a
PI3K-dependent manner [30]. Our results also showed
that Appl2 can interact with Appl1when challenged by
LPS. These results indicate that a complex formed by
Appl1, Appl2 and PI3K likely exists, and Appl2 has a
negative effect on the activation of PI3K/Akt pathway
and therefore, the expression of downstream genes in-
volved in inflammation.
In our experiment, Appl2 KO mice exhibited symp-
toms of more severe endotoxin shock and increased pro-
duction of serum proinflammatory cytokines whenFigure 8 Decreased production of TNFα and IL-1β and reduced activa
macrophages. Peritoneal macrophages derived from peritoneal cells were
was collected for quantification of cytokine (TNFα and IL-1β) expression. Th
TNFα and IL-1β expression in the LPS-stimulated primary macrophages from t
macrophages from Appl1 KO mice with the indicated antibodies. (D) The rati
p-p65/p65/β-actin as determined by the density analysis of (C) using NIH Imachallenged with LPS. Although the precise mechanism is
not known at this point, it is perceivable that absence of
Appl2 enhances the interaction between Appl1 and
PI3K and hence further activates the Akt signaling path-
way and subsequent inflammatory responses. Indeed, de-
letion of Appl1exhibited characteristics of reduced Akt
activation and decreased inflammatory response.
Conclusions
Findings of the present study show that Appl2 is an im-
portant negative regulator in PI3K/Akt-mediated NF-kB
activation and therefore serves as a target with great
therapeutic potential to curb inflammation.tion of Akt-NF-κB pathways after LPS stimulation in Appl1 KO
stimulated with 1 μg/mL LPS at specified times and the supernant
e cell lysates were analyzed by western blot. (A-B) Time course of
he Appl1 KO and control mice. (C) Western blot analysis on peritoneal
o values of p-Akt/Akt/β-actin, p-IKKβ/IKKβ/β-actin, p-IκB/IκB/β-actin, and
ge J software for relative values. *p < 0.05, compared with WT mice, n = 5.
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Generation of Appl1 and Appl2 KO mice
Generation of Appl1 and Appl2 KO mice has been de-
scribed previously [30,36]. Briefly, a 4.7 kb genomic frag-
ment upstream of mouse Appl1 exon 17 and a 4.2 kb
genomic fragment downstream from Appl1 exon 18
were used as the recombination arms in the construc-
tion of the targeting vector. A neomycin-resistance gene
(neo) expression cassette was inserted between the two
regions, which resulted in a vector designed to delete
the two RNA-binding motifs in an exon 17 and 18. A
3.4 kb and a 3.6 kb genomic fragment upstream and
downstream of mouse Appl2 exon 5 were used as re-
combination arms, respectively, in the construction of
the targeting vectors. A neocassette with the loxP se-
quence was inserted into the upstream of exon 5. An-
other loxP site was cloned into downstream of exon 5.
Both the two targeting vectors were performed accord-
ing to protocol: C57BL/6 J embryonic stem (ES) cells
were electroporated with the linearized targeting con-
struct [37,38]. After selected by G418, clones with tar-
geted alleles were identified through polymerase chain
reaction (PCR) analysis. ES cells with targeted alleles
were injected into the blastocysts of C57BL/6 J mice.
The chimeric males were mated with the females of the
same strain to obtain heterozygous mutant mice. The
Appl1 mice intercrossed to obtain homozygous and
wild-type (WT) mice. Then the Appl2-floxed mice were
crossed with EIIA-Cre mice, and the homozygous Appl2
KO mice were subsequently generated from these mice.
Animal and ethics statement
Male APPL1/2 KO mice in C57BL/6 background and
WT mice were housed in standard specified pathogen-
free mice room and maintained on a 12 h light–dark
cycle at 22 ± 2°C and fed standard chow (15.9 kJ/g, 10%
of energy as fat, 20% of energy as protein, 70% of energy
as carbohydrate). Humane endpoints of animal behaviors
were used to minimize suffering in the survival and ani-
mal studies. All intraperitoneal injections and sacrifice
for organ removal and peritoneal macrophages isolation
were performed under anesthesia by sodium pentobar-
bital (50 mg/kg, i.p.). All of the experimental procedures
were carried out in accordance with the NIH Guidelines
for the Care and Use of Laboratory Animals. Animal ex-
periments were approved by the Animal Care and Use
Committee of Guangzhou Institute of Biomedicine and
Health, Chinese Academy of Sciences.
Survival studies
Male mice (8 weeks old) weighing 21 ± 2 g were treated
once with intraperitoneal injection of LPS (Sigma-Aldrich)
one time. The Appl2 KO and WT mice were injected with
a dose of LPS at 20 mg/kg weight (n = 9). The mice werereturned to their cages after LPS injection and closely
monitored for their behaviors during the experiments
every eight hours. Mice were given ad libitum access to
food and water at all times. In case clinical signs of distress
or moribund were recognized, animals were euthanized by
sodium pentobarbital (50 mg/kg, i.p.) followed by cervical
dislocation. Clinical signs of endotoxin shock include re-
duced locomotion, signs of diarrhea, piloerection and
body weight loss. The number of survival mice was re-
corded at the time points of 24 h, 48 h, 72 h after LPS
challenge, and the percent survival rates were calculated
from the number of animals that survived by the total
number of tested animals at the given time. The Appl1
KO and WT mice were injected with a dose of LPS at
30 mg/kg weight (n = 9), and the survival rate experiment
was performed as above.
Serum and tissue samples
Appl1/2 KO and WT control mice were injected i.p.
with LPS as described. Whole blood samples were col-
lected into tubes containing an anticoagulant by tail inci-
sion at the time points of 1 h, 12 h, 24 h, 48 h, 72 h
after LPS challenge and incubated at room temperature
for 15 min prior to centrifugation at 3,000 × g for
20 min. The tail wounds of mice were wiped by the 70%
alcohol cotton ball to prevent infection. The serum was
extracted and stored at −80°C before processing for
cytokine assays.
Histochemistry
The mice were euthanized by cervical dislocation under
anesthesia by sodium pentobarbital (50 mg/kg, i.p.) after
24 h by LPS injection, and the kidney tissues were fixed
in 4% formaldehyde overnight at room temperature im-
mediately after the mice were sacrificed. Tissues were
paraffinized and sectioned by microtome, and the slides
were stained with hematoxilin and eosin (HE) (Sigma)
following the standard protocol. Sections were examined
by light microscopy.
Isolation and culture of peritoneal macrophages for
in vitro studies
Peritoneal macrophages from C57BL/6 mice and Appl1/
2 KO mice were collected as previously described [39].
Briefly, peritoneal macrophages were elicited by an
intra-peritoneal injection of 2 ml of 4% thioglycolate
(Gibco) in distilled water. After 4 days, the elicited mac-
rophages were collected by peritoneal lavage with 10
mlof Hank's balanced salt solution (HBSS). The periton-
eal lavage fluids were centrifuged at 1500 rpm for 5 min
and the cells were re-suspended in RPMI-1640 medium
(Invitrogen) supplemented with 10% heat-inactivated
fetal calf serum, 100 units/ml penicillin, and 100 μg/ml
streptomycin. Equal numbers of peritoneal macrophages
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wells (5 × 105 cells/well). Peritoneal cells were incubated at
37°C in an atmosphere of 5% CO2 for 3 h to allow the
peritoneal macrophages to adhere. Non-adherent cells
were removed by washing with PBS twice and the attached
cells were used as peritoneal macrophages.
Quantification of cytokine expression
Serum cytokine levels and cytokines secreted from pri-
mary macrophages were examined through ELISA (R&D).
The macrophages were stimulated with 1 μg/mL LPS
(Sigma) at specified times and the supernatant was col-
lected for quantification of cytokine (TNFα and IL-1β)
expression.
Western blot analysis
Peritoneal macrophages were treated with 1 μg/mL LPS
for 20 minutes. Peritoneal macrophages were washed with
ice-cold PBS, and proteins were extracted from the cells in
a RIPA buffer (Beyotime). The concentration of protein in
the lysate was determined using a Bradford assay (Bio-
Rad). The cell lysates were resolved through SDS-PAGE
and transferred onto a polyvinylidene fluoride membrane.
The membrane was blotted with antibodies to Akt (Cell
Signaling), p65 (Cell Signaling), IκB (Cell Signaling), IKKβ
(Cell Signaling), phospho-Akt (Cell Signaling), phospho-
IKKβ (Abcam), phospho- IκBα (Cell Signaling), phospho-
p65 (Cell Signaling), Appl1, and Appl2. Appl1 and Appl2
antibodies were from Aimin Xu.
Immunoprecipitation
Peritoneal macrophages were treated with 1 μg/mL LPS
for 20 min. The cells were washed with PBS and pro-
teins were extracted via treatment with RIPA buffer
(Beyotime) at 4°C for 30 minutes. Cells were centrifuged
at 10,000 g for 30 minutes at 4°C, allowing cell debris to
be pelleted and discarded. Cellular protein (100 μg) was
mixed with 1 μg of anti-Appl1 or Appl2 antibody and
incubated over-night at 4°C. Then, 10 μl of protein G
Plus-agarose (Santa Cruz) was added to these samples
and incubated for another 4 h at 4°C. After the incuba-
tion, samples were washed three times with lysis buffer.
The washed samples were re-suspended in SDS sample
buffer (Beyotime) and heated at 100°C for 5 min prior to
electrophoresis.
Statistical analysis
In order to examine the survival rate of APPl1/2 KO
and WT mice when challenged by LPS, a Kaplan-Meier
analysis was performed using terminal mortality as the
endpoint. Data were presented as mean ± SD for the stat-
istical comparison of the two samples. Student’s t-test was
used for evaluation. Survival curves were generated usingthe Kaplan-Meier method, and their significance was eval-
uated using the Log-rank test.
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IL-1β: Interleukin 1β; NF-κB: Nuclear factor κB; TNF-α: Tumour necrosis factor-α;
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kinase B; IKK: IκB kinase; TLR4: Toll-like receptor4; MyD88: Myeloid differentiation
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